PMC:7283670 / 55886-56315 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T201","span":{"begin":66,"end":71},"obj":"Body_part"},{"id":"T202","span":{"begin":409,"end":413},"obj":"Body_part"}],"attributes":[{"id":"A201","pred":"fma_id","subj":"T201","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A202","pred":"fma_id","subj":"T202","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T133","span":{"begin":66,"end":71},"obj":"Body_part"}],"attributes":[{"id":"A133","pred":"uberon_id","subj":"T133","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T538","span":{"begin":66,"end":71},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T539","span":{"begin":106,"end":111},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T540","span":{"begin":407,"end":413},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T54548","span":{"begin":112,"end":119},"obj":"Chemical"}],"attributes":[{"id":"A80547","pred":"chebi_id","subj":"T54548","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T609","span":{"begin":18,"end":85},"obj":"Sentence"},{"id":"T610","span":{"begin":86,"end":198},"obj":"Sentence"},{"id":"T611","span":{"begin":199,"end":322},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1879","span":{"begin":356,"end":359},"obj":"Gene"}],"attributes":[{"id":"A1879","pred":"tao:has_database_id","subj":"1879","obj":"Gene:1401"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Primary (9 days): The relief/disappearance rate of main symptoms, chest CT absorption\nSecondary (9 days): virus antigen negative conversion rate, Clinical effective time: the average effective time. The number of severe and critical conversion cases, Incidence of complications, Traditional Chinese Medicine Syndrome Score\nOther outcome measures (9 days): CRP changes, ESR changes, PCTchanges, The index of T cell subsets changed"}